In vitro metabolite identification of ML3403, a 4-pyridinylimidazole-type p38 MAP kinase inhibitor by LC-Qq-TOF-MS and LC-SPE-cryo-NMR/MS

Author: Kammerer B.   Scheible H.   Zurek G.   Godejohann M.   Zeller K. -P.   Gleiter C. H.   Albrecht W.   Laufer S.  

Publisher: Informa Healthcare

ISSN: 1366-5928

Source: Xenobiotica, Vol.37, Iss.3, 2007-03, pp. : 280-297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content